Advertisement

Index by author

February 01, 1988; Volume 33,Issue 2

A

  1. Agui, T

    1. Binding of [125I]-N-(p-aminophenethyl)spiroperidol to the D-2 dopamine receptor in the neurointermediate lobe of the rat pituitary gland: a thermodynamic study.
      T Agui, N Amlaiky, M G Caron and J W Kebabian
      Molecular Pharmacology February 1988, 33 (2) 163-169;

  2. Aiyar, N

    1. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
      F L Stassen, G Heckman, D Schmidt, M T Papadopoulos, P Nambi, H Sarau, N Aiyar, M Gellai and L Kinter
      Molecular Pharmacology February 1988, 33 (2) 218-224;

  3. Akiyama, S

    1. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
      S Akiyama, M M Cornwell, M Kuwano, I Pastan and M M Gottesman
      Molecular Pharmacology February 1988, 33 (2) 144-147;

  4. Amlaiky, N

    1. Binding of [125I]-N-(p-aminophenethyl)spiroperidol to the D-2 dopamine receptor in the neurointermediate lobe of the rat pituitary gland: a thermodynamic study.
      T Agui, N Amlaiky, M G Caron and J W Kebabian
      Molecular Pharmacology February 1988, 33 (2) 163-169;

  5. Andorn, A C

    1. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
      A C Andorn, B R Bacon, A T Nguyen-Hunh, S J Parlato and J A Stitts
      Molecular Pharmacology February 1988, 33 (2) 155-162;

  6. Arlotto, M P

    1. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities.
      B Astroff, T Zacharewski, S Safe, M P Arlotto, A Parkinson, P Thomas and W Levin
      Molecular Pharmacology February 1988, 33 (2) 231-236;

  7. Astroff, B

    1. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities.
      B Astroff, T Zacharewski, S Safe, M P Arlotto, A Parkinson, P Thomas and W Levin
      Molecular Pharmacology February 1988, 33 (2) 231-236;

B

  1. Bacon, B R

    1. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
      A C Andorn, B R Bacon, A T Nguyen-Hunh, S J Parlato and J A Stitts
      Molecular Pharmacology February 1988, 33 (2) 155-162;

  2. Bellward, G D

    1. Hepatic cytochrome P-450j induction in the spontaneously diabetic BB rat.
      G D Bellward, T Chang, B Rodrigues, J H McNeill, S Maines, D E Ryan, W Levin and P E Thomas
      Molecular Pharmacology February 1988, 33 (2) 140-143;

  3. Benishin, C G

    1. Phenothiazines and haloperidol block Ca-activated K channels in rat forebrain synaptosomes.
      C G Benishin, B K Krueger and M P Blaustein
      Molecular Pharmacology February 1988, 33 (2) 195-201;

  4. Bidlack, J M

    1. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
      J M Bidlack, W E O'Malley and R Schulz
      Molecular Pharmacology February 1988, 33 (2) 170-177;

  5. Blaustein, M P

    1. Phenothiazines and haloperidol block Ca-activated K channels in rat forebrain synaptosomes.
      C G Benishin, B K Krueger and M P Blaustein
      Molecular Pharmacology February 1988, 33 (2) 195-201;

  6. Bockaert, J

    1. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
      A Dumuis, M Sebben and J Bockaert
      Molecular Pharmacology February 1988, 33 (2) 178-186;

  7. Boston, R C

    1. Daunomycin-DNA dissociation kinetics.
      D R Phillips, P C Greif and R C Boston
      Molecular Pharmacology February 1988, 33 (2) 225-230;

  8. Bouvier, M

    1. Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
      M Bouvier, M Hnatowich, S Collins, B K Kobilka, A Deblasi, R J Lefkowitz and M G Caron
      Molecular Pharmacology February 1988, 33 (2) 133-139;

  9. Brady, J F

    1. Diethyl ether as a substrate for acetone/ethanol-inducible cytochrome P-450 and as an inducer for cytochrome(s) P-450.
      J F Brady, M J Lee, M Li, H Ishizaki and C S Yang
      Molecular Pharmacology February 1988, 33 (2) 148-154;

C

  1. Carlsen, R C

    1. Calcium-dependent regulation of phosphorylase activation in a fast-twitch oxidative-glycolytic skeletal muscle.
      L P Garetto, R C Carlsen, J H Lee and D A Walsh
      Molecular Pharmacology February 1988, 33 (2) 212-217;

  2. Caron, M G

    1. Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
      M Bouvier, M Hnatowich, S Collins, B K Kobilka, A Deblasi, R J Lefkowitz and M G Caron
      Molecular Pharmacology February 1988, 33 (2) 133-139;
    2. Binding of [125I]-N-(p-aminophenethyl)spiroperidol to the D-2 dopamine receptor in the neurointermediate lobe of the rat pituitary gland: a thermodynamic study.
      T Agui, N Amlaiky, M G Caron and J W Kebabian
      Molecular Pharmacology February 1988, 33 (2) 163-169;

  3. Chang, T

    1. Hepatic cytochrome P-450j induction in the spontaneously diabetic BB rat.
      G D Bellward, T Chang, B Rodrigues, J H McNeill, S Maines, D E Ryan, W Levin and P E Thomas
      Molecular Pharmacology February 1988, 33 (2) 140-143;

  4. Collins, S

    1. Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
      M Bouvier, M Hnatowich, S Collins, B K Kobilka, A Deblasi, R J Lefkowitz and M G Caron
      Molecular Pharmacology February 1988, 33 (2) 133-139;

  5. Cornwell, M M

    1. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
      S Akiyama, M M Cornwell, M Kuwano, I Pastan and M M Gottesman
      Molecular Pharmacology February 1988, 33 (2) 144-147;

D

  1. Deblasi, A

    1. Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
      M Bouvier, M Hnatowich, S Collins, B K Kobilka, A Deblasi, R J Lefkowitz and M G Caron
      Molecular Pharmacology February 1988, 33 (2) 133-139;

  2. Dumuis, A

    1. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
      A Dumuis, M Sebben and J Bockaert
      Molecular Pharmacology February 1988, 33 (2) 178-186;

E

  1. Ehlert, F J

    1. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
      F J Ehlert
      Molecular Pharmacology February 1988, 33 (2) 187-194;

G

  1. Garetto, L P

    1. Calcium-dependent regulation of phosphorylase activation in a fast-twitch oxidative-glycolytic skeletal muscle.
      L P Garetto, R C Carlsen, J H Lee and D A Walsh
      Molecular Pharmacology February 1988, 33 (2) 212-217;

  2. Gellai, M

    1. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
      F L Stassen, G Heckman, D Schmidt, M T Papadopoulos, P Nambi, H Sarau, N Aiyar, M Gellai and L Kinter
      Molecular Pharmacology February 1988, 33 (2) 218-224;

  3. Gottesman, M M

    1. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
      S Akiyama, M M Cornwell, M Kuwano, I Pastan and M M Gottesman
      Molecular Pharmacology February 1988, 33 (2) 144-147;

  4. Greif, P C

    1. Daunomycin-DNA dissociation kinetics.
      D R Phillips, P C Greif and R C Boston
      Molecular Pharmacology February 1988, 33 (2) 225-230;

H

  1. Heckman, G

    1. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
      F L Stassen, G Heckman, D Schmidt, M T Papadopoulos, P Nambi, H Sarau, N Aiyar, M Gellai and L Kinter
      Molecular Pharmacology February 1988, 33 (2) 218-224;

  2. Hnatowich, M

    1. Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
      M Bouvier, M Hnatowich, S Collins, B K Kobilka, A Deblasi, R J Lefkowitz and M G Caron
      Molecular Pharmacology February 1988, 33 (2) 133-139;

  3. Hsu, M C

    1. Photoaffinity labeling of human placental monoamine oxidase-A by 4-fluoro-3-nitrophenyl azide.
      M C Hsu and J C Shih
      Molecular Pharmacology February 1988, 33 (2) 237-241;

I

  1. Ishizaki, H

    1. Diethyl ether as a substrate for acetone/ethanol-inducible cytochrome P-450 and as an inducer for cytochrome(s) P-450.
      J F Brady, M J Lee, M Li, H Ishizaki and C S Yang
      Molecular Pharmacology February 1988, 33 (2) 148-154;

K

  1. Kebabian, J W

    1. Binding of [125I]-N-(p-aminophenethyl)spiroperidol to the D-2 dopamine receptor in the neurointermediate lobe of the rat pituitary gland: a thermodynamic study.
      T Agui, N Amlaiky, M G Caron and J W Kebabian
      Molecular Pharmacology February 1988, 33 (2) 163-169;

  2. Kinter, L

    1. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
      F L Stassen, G Heckman, D Schmidt, M T Papadopoulos, P Nambi, H Sarau, N Aiyar, M Gellai and L Kinter
      Molecular Pharmacology February 1988, 33 (2) 218-224;

  3. Kobilka, B K

    1. Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
      M Bouvier, M Hnatowich, S Collins, B K Kobilka, A Deblasi, R J Lefkowitz and M G Caron
      Molecular Pharmacology February 1988, 33 (2) 133-139;

  4. Krueger, B K

    1. Phenothiazines and haloperidol block Ca-activated K channels in rat forebrain synaptosomes.
      C G Benishin, B K Krueger and M P Blaustein
      Molecular Pharmacology February 1988, 33 (2) 195-201;

  5. Kuwano, M

    1. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
      S Akiyama, M M Cornwell, M Kuwano, I Pastan and M M Gottesman
      Molecular Pharmacology February 1988, 33 (2) 144-147;

L

  1. Lee, J H

    1. Calcium-dependent regulation of phosphorylase activation in a fast-twitch oxidative-glycolytic skeletal muscle.
      L P Garetto, R C Carlsen, J H Lee and D A Walsh
      Molecular Pharmacology February 1988, 33 (2) 212-217;

  2. Lee, M J

    1. Diethyl ether as a substrate for acetone/ethanol-inducible cytochrome P-450 and as an inducer for cytochrome(s) P-450.
      J F Brady, M J Lee, M Li, H Ishizaki and C S Yang
      Molecular Pharmacology February 1988, 33 (2) 148-154;

  3. Lefkowitz, R J

    1. Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
      M Bouvier, M Hnatowich, S Collins, B K Kobilka, A Deblasi, R J Lefkowitz and M G Caron
      Molecular Pharmacology February 1988, 33 (2) 133-139;

  4. Levin, W

    1. Hepatic cytochrome P-450j induction in the spontaneously diabetic BB rat.
      G D Bellward, T Chang, B Rodrigues, J H McNeill, S Maines, D E Ryan, W Levin and P E Thomas
      Molecular Pharmacology February 1988, 33 (2) 140-143;
    2. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities.
      B Astroff, T Zacharewski, S Safe, M P Arlotto, A Parkinson, P Thomas and W Levin
      Molecular Pharmacology February 1988, 33 (2) 231-236;

  5. Li, M

    1. Diethyl ether as a substrate for acetone/ethanol-inducible cytochrome P-450 and as an inducer for cytochrome(s) P-450.
      J F Brady, M J Lee, M Li, H Ishizaki and C S Yang
      Molecular Pharmacology February 1988, 33 (2) 148-154;

M

  1. Mahar, J

    1. Multiple saxitoxin-binding sites in bullfrog muscle: tetrodotoxin-sensitive sodium channels and tetrodotoxin-insensitive sites of unknown function.
      E Moczydlowski, J Mahar and A Ravindran
      Molecular Pharmacology February 1988, 33 (2) 202-211;

  2. Maines, S

    1. Hepatic cytochrome P-450j induction in the spontaneously diabetic BB rat.
      G D Bellward, T Chang, B Rodrigues, J H McNeill, S Maines, D E Ryan, W Levin and P E Thomas
      Molecular Pharmacology February 1988, 33 (2) 140-143;

  3. McNeill, J H

    1. Hepatic cytochrome P-450j induction in the spontaneously diabetic BB rat.
      G D Bellward, T Chang, B Rodrigues, J H McNeill, S Maines, D E Ryan, W Levin and P E Thomas
      Molecular Pharmacology February 1988, 33 (2) 140-143;

  4. Moczydlowski, E

    1. Multiple saxitoxin-binding sites in bullfrog muscle: tetrodotoxin-sensitive sodium channels and tetrodotoxin-insensitive sites of unknown function.
      E Moczydlowski, J Mahar and A Ravindran
      Molecular Pharmacology February 1988, 33 (2) 202-211;

N

  1. Nambi, P

    1. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
      F L Stassen, G Heckman, D Schmidt, M T Papadopoulos, P Nambi, H Sarau, N Aiyar, M Gellai and L Kinter
      Molecular Pharmacology February 1988, 33 (2) 218-224;

  2. Nestler, E J

    1. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus.
      E J Nestler and J F Tallman
      Molecular Pharmacology February 1988, 33 (2) 127-132;

  3. Nguyen-Hunh, A T

    1. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
      A C Andorn, B R Bacon, A T Nguyen-Hunh, S J Parlato and J A Stitts
      Molecular Pharmacology February 1988, 33 (2) 155-162;

O

  1. O'Malley, W E

    1. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
      J M Bidlack, W E O'Malley and R Schulz
      Molecular Pharmacology February 1988, 33 (2) 170-177;

P

  1. Papadopoulos, M T

    1. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
      F L Stassen, G Heckman, D Schmidt, M T Papadopoulos, P Nambi, H Sarau, N Aiyar, M Gellai and L Kinter
      Molecular Pharmacology February 1988, 33 (2) 218-224;

  2. Parkinson, A

    1. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities.
      B Astroff, T Zacharewski, S Safe, M P Arlotto, A Parkinson, P Thomas and W Levin
      Molecular Pharmacology February 1988, 33 (2) 231-236;

  3. Parlato, S J

    1. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
      A C Andorn, B R Bacon, A T Nguyen-Hunh, S J Parlato and J A Stitts
      Molecular Pharmacology February 1988, 33 (2) 155-162;

  4. Pastan, I

    1. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
      S Akiyama, M M Cornwell, M Kuwano, I Pastan and M M Gottesman
      Molecular Pharmacology February 1988, 33 (2) 144-147;

  5. Phillips, D R

    1. Daunomycin-DNA dissociation kinetics.
      D R Phillips, P C Greif and R C Boston
      Molecular Pharmacology February 1988, 33 (2) 225-230;

R

  1. Ravindran, A

    1. Multiple saxitoxin-binding sites in bullfrog muscle: tetrodotoxin-sensitive sodium channels and tetrodotoxin-insensitive sites of unknown function.
      E Moczydlowski, J Mahar and A Ravindran
      Molecular Pharmacology February 1988, 33 (2) 202-211;

  2. Rodrigues, B

    1. Hepatic cytochrome P-450j induction in the spontaneously diabetic BB rat.
      G D Bellward, T Chang, B Rodrigues, J H McNeill, S Maines, D E Ryan, W Levin and P E Thomas
      Molecular Pharmacology February 1988, 33 (2) 140-143;

  3. Ryan, D E

    1. Hepatic cytochrome P-450j induction in the spontaneously diabetic BB rat.
      G D Bellward, T Chang, B Rodrigues, J H McNeill, S Maines, D E Ryan, W Levin and P E Thomas
      Molecular Pharmacology February 1988, 33 (2) 140-143;

S

  1. Safe, S

    1. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities.
      B Astroff, T Zacharewski, S Safe, M P Arlotto, A Parkinson, P Thomas and W Levin
      Molecular Pharmacology February 1988, 33 (2) 231-236;

  2. Sarau, H

    1. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
      F L Stassen, G Heckman, D Schmidt, M T Papadopoulos, P Nambi, H Sarau, N Aiyar, M Gellai and L Kinter
      Molecular Pharmacology February 1988, 33 (2) 218-224;

  3. Schmidt, D

    1. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
      F L Stassen, G Heckman, D Schmidt, M T Papadopoulos, P Nambi, H Sarau, N Aiyar, M Gellai and L Kinter
      Molecular Pharmacology February 1988, 33 (2) 218-224;

  4. Schulz, R

    1. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor.
      J M Bidlack, W E O'Malley and R Schulz
      Molecular Pharmacology February 1988, 33 (2) 170-177;

  5. Sebben, M

    1. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
      A Dumuis, M Sebben and J Bockaert
      Molecular Pharmacology February 1988, 33 (2) 178-186;

  6. Shih, J C

    1. Photoaffinity labeling of human placental monoamine oxidase-A by 4-fluoro-3-nitrophenyl azide.
      M C Hsu and J C Shih
      Molecular Pharmacology February 1988, 33 (2) 237-241;

  7. Stassen, F L

    1. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
      F L Stassen, G Heckman, D Schmidt, M T Papadopoulos, P Nambi, H Sarau, N Aiyar, M Gellai and L Kinter
      Molecular Pharmacology February 1988, 33 (2) 218-224;

  8. Stitts, J A

    1. Guanyl nucleotide interactions with dopaminergic binding sites labeled by [3H]spiroperidol in human caudate and putamen: guanyl nucleotides enhance ascorbate-induced lipid peroxidation and cause an apparent loss of high affinity binding sites.
      A C Andorn, B R Bacon, A T Nguyen-Hunh, S J Parlato and J A Stitts
      Molecular Pharmacology February 1988, 33 (2) 155-162;

T

  1. Tallman, J F

    1. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus.
      E J Nestler and J F Tallman
      Molecular Pharmacology February 1988, 33 (2) 127-132;

  2. Thomas, P

    1. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities.
      B Astroff, T Zacharewski, S Safe, M P Arlotto, A Parkinson, P Thomas and W Levin
      Molecular Pharmacology February 1988, 33 (2) 231-236;

  3. Thomas, P E

    1. Hepatic cytochrome P-450j induction in the spontaneously diabetic BB rat.
      G D Bellward, T Chang, B Rodrigues, J H McNeill, S Maines, D E Ryan, W Levin and P E Thomas
      Molecular Pharmacology February 1988, 33 (2) 140-143;

W

  1. Walsh, D A

    1. Calcium-dependent regulation of phosphorylase activation in a fast-twitch oxidative-glycolytic skeletal muscle.
      L P Garetto, R C Carlsen, J H Lee and D A Walsh
      Molecular Pharmacology February 1988, 33 (2) 212-217;

Y

  1. Yang, C S

    1. Diethyl ether as a substrate for acetone/ethanol-inducible cytochrome P-450 and as an inducer for cytochrome(s) P-450.
      J F Brady, M J Lee, M Li, H Ishizaki and C S Yang
      Molecular Pharmacology February 1988, 33 (2) 148-154;

Z

  1. Zacharewski, T

    1. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities.
      B Astroff, T Zacharewski, S Safe, M P Arlotto, A Parkinson, P Thomas and W Levin
      Molecular Pharmacology February 1988, 33 (2) 231-236;
Back to top

In this issue